PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.\', \'Institute of Pharmacology, Toxicology, and Pharmacy, Ludwig-Maximilians-University (LMU), Königinstr. 16, D-80539, Munich, Germany.\', \'Hamdard Institute of Medical Sciences and Research, New Delhi, India.\', \'Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.\', \'Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. Electronic address: dvohora@jamiahamdard.ac.in.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0920-1211(21)00128-510.1016/j.eplepsyres.2021.106675
?:doi
?:hasPublicationType
?:journal
  • Epilepsy research
is ?:pmid of
?:pmid
?:pmid
  • 34044300
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.956
?:rankingScore_hIndex
  • 104
is ?:relation_isRelatedTo_publication of
?:title
  • Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34044300>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34044300>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all